Allopurinol, uric acid, and oxidative stress in cardiorenal disease.
about
Gout increases risk of fracture: A nationwide population-based cohort study.Uric acid as one of the important factors in multifactorial disorders--facts and controversies.Fructose and uric acid: is there a role in endothelial function?Association between allopurinol and mortality among Japanese hemodialysis patients: results from the DOPPS.Comparative study of renal protective effects of allopurinol and N-acetyl-cysteine on contrast induced nephropathy in patients undergoing cardiac catheterizationXanthine oxidase inhibition alleviates the cardiac complications of insulin resistance: effect on low grade inflammation and the angiotensin system.Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease.Preconditioning with Azadirachta indica ameliorates cardiorenal dysfunction through reduction in oxidative stress and extracellular signal regulated protein kinase signalling.Uric acid is an important predictor for hypertensive early atherosclerosis.The Future Challenge of Reactive Oxygen Species (ROS) in Hypertension: From Bench to Bed Side.Relationship between serum uric acid and mortality among hemodialysis patients: Retrospective analysis of Korean end-stage renal disease registry data.Rutin inhibits coronary heart disease through ERK1/2 and Akt signaling in a porcine model.Zingerone alleviates the delayed ventricular repolarization and AV conduction in diabetes: Effect on cardiac fibrosis and inflammation.Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure.The association between serum uric acid and blood pressure in different age groups in a healthy Chinese cohort.Kolaviron attenuated arsenic acid induced-cardiorenal dysfunction via regulation of ROS, C-reactive proteins (CRP), cardiac troponin I (CTnI) and BCL2.
P2860
Q33590612-28DDF5FB-E782-42E3-AAD6-65401042FA5DQ33773142-BC0B437B-8148-403F-AB9F-22339CE5FE46Q33854358-5C09E108-A962-4DFE-AE94-200381CB264BQ34100586-DFEF6A67-F5DF-498D-B1CF-F5891BEAF945Q35046376-7F9BE628-9723-45B0-8738-7B036B617889Q35166562-B0191E8E-D289-49B7-B995-446700FD87B4Q36189989-9DB2BF34-A1AD-4718-83A0-5EFA02F758E0Q37538978-68AE3B4C-7FA7-436F-A06A-F76960DF23EDQ39644586-2EC3043F-2F02-419D-A9CA-EE3DCCE76AA8Q41660449-1762759E-423A-4E5E-A71F-8E499DFCCAABQ47109222-BD124A1B-85C5-46EB-85B3-C60D69AC0721Q47109401-F928288C-D1B0-4754-B4E0-FC3557F24252Q47144195-FEA191C3-4BEC-4315-999C-59A675B21E10Q48716818-24E8826A-369B-492A-A677-95184C06835DQ49487971-8FFFDA2C-196E-44AB-884A-F67FBE8A58B6Q55497728-459D5A68-199A-4E14-8618-9C4E8808C733
P2860
Allopurinol, uric acid, and oxidative stress in cardiorenal disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Allopurinol, uric acid, and oxidative stress in cardiorenal disease.
@en
Allopurinol, uric acid, and oxidative stress in cardiorenal disease.
@nl
type
label
Allopurinol, uric acid, and oxidative stress in cardiorenal disease.
@en
Allopurinol, uric acid, and oxidative stress in cardiorenal disease.
@nl
prefLabel
Allopurinol, uric acid, and oxidative stress in cardiorenal disease.
@en
Allopurinol, uric acid, and oxidative stress in cardiorenal disease.
@nl
P2860
P1476
Allopurinol, uric acid, and oxidative stress in cardiorenal disease.
@en
P2093
David Goldsmith
Markus Riegersperger
P2860
P304
P356
10.1007/S11255-011-9929-6
P50
P577
2011-03-10T00:00:00Z